U.S. markets closed
  • S&P 500

    4,117.86
    -46.14 (-1.11%)
     
  • Dow 30

    33,949.01
    -207.68 (-0.61%)
     
  • Nasdaq

    11,910.52
    -203.27 (-1.68%)
     
  • Russell 2000

    1,942.60
    -30.01 (-1.52%)
     
  • Crude Oil

    78.48
    +1.34 (+1.74%)
     
  • Gold

    1,888.20
    +3.40 (+0.18%)
     
  • Silver

    22.34
    +0.17 (+0.76%)
     
  • EUR/USD

    1.0717
    -0.0014 (-0.13%)
     
  • 10-Yr Bond

    3.6530
    -0.0210 (-0.57%)
     
  • GBP/USD

    1.2071
    +0.0019 (+0.16%)
     
  • USD/JPY

    131.3290
    +0.2570 (+0.20%)
     
  • BTC-USD

    22,962.62
    -224.61 (-0.97%)
     
  • CMC Crypto 200

    529.21
    -7.68 (-1.43%)
     
  • FTSE 100

    7,885.17
    +20.46 (+0.26%)
     
  • Nikkei 225

    27,606.46
    -79.01 (-0.29%)
     

Ardelyx Stock Skyrockets After Its Kidney Disease Drug Gets a Surprise Step Closer to FDA Approval

Ardelyx Stock Skyrockets After Its Kidney Disease Drug Gets a Surprise Step Closer to FDA Approval

In a surprise move, a committee of the agency’s outside advisors voted in favor of the proposition that the drug's benefits outweigh its risks.